Rising Cancer Cases in India Highlight Treatment Costs and Access Challenges

India faces a rising cancer burden, with over 15 lakh new cases reported in 2024 and projections indicating a 67% increase by 2045. While advanced treatments and government measures like customs duty waivers on 17 essential cancer drugs aim to reduce costs, many patients still face significant financial challenges. Treatment expenses can reach up to Rs 30 lakh, often exceeding insurance coverage, leading to delays or abandonment of therapy, especially in rural areas. Experts emphasize the need for improved access and early care to enhance patient outcomes.